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OlijecPivos. This study investigates wWber repeat mro~ 
intervmtio~ applied over aa extended time period, can snccess- 
futiy curtail the progression of is&en& symptoms and aagiu- 
graphic huue?J llamhg. 
Boekgmud Corumuy artery disease is a chronic and generaRy 
progressive disorder, and potential treatment strategies should be 
ous intemntional revasctdarhation pmc&ues could tbeoreti- 
c&y be n&id in mntroRiug progression of the disease tltroagh 
repeated use as new mmary lesions arise. However, the outcome 
of this long-term management mocept kas not previously keen 
sm to de&Red investigation 
Mf&&v.Froma maisecative se&s of 4357 i~terventianal 
cardiac pm 544 patients were- ides&led who received hvo 
or more iuterveations duriq the U-year study period. These 
patieats were categoriaed iato oue of three grwups: lV.WWis 
(repat interventions limited to the same target segment, 0 = 
26l),mwsten& (au repeat interventions directed to stenoses not 
wwhpated,n= 155) or 6&i (repeat intetveatious diied 
botktot8es~sndtodiflerentLargetlesi~n=128). 
lbu&s.%votoRvepzxtdmewereperfomtedperpatien~tbe 
time period (raeaa i SD) separating eafh pmcedure was siguif- 
icaatiy less (p < 0,0001) for the restenosis group (4.2 * 2.3 
The use of coronary angioplasty and related interventional 
procedures has proved (1) to be clinically helpful in the 
management of the acute manifestations of coronary artery 
disease. Relative to medical therapy, continued subjective and 
objective improvement have been documented (2) for ~6 
months after the procedure. Retrospective uncontrolled anal- 
yses (3-6) have also provided insight into effectiveness of this 
&at&y 5 to 10 years later. 
‘The primary alternative to percutaneous intervention is 
Fmm the Uniwity of Washington School of Medicine, Seattle, Weddng- 
tm and WCS Tlmmxcenter. Erasmus Uniwmitv. Rotterdam. The Nedxrlands. 
mods) than for the new steuusis (24.2 * 235 months) or the 
%otk” groups (11.4 + 11.0 months). Despite tke need for repeat 
procedures, the severity of angina (mean New York Heart Asso- 
ciation fimctional class 1.6 + 0.9) aRer 6.2 + 2.3 years of 
fotlow-up was substantially better than before tke initial proce- 
dure (mean functional class 3.2 * 0.8), with a similar maguitude 
of cbaage fouad in all thee groups. This long-term hmctional 
improvement was mirrored by a mrresponding aaatomic improve- 
ment, with the mean number of diseased vessels remaining 
constaut at the time of each pmcedure (1.5 + 0.7, 1.5 + 0.7 and 
1.6 f 0.7, respective& for the Rrst, second and third procedures, 
= NS). The restenosis and the oew steuosis groups also 
Laonstrated statistkaRy slmii annual rates of q ortaRty (1.9% 
vs. l.%) and mrotwy .sqe~ (2.3% vs. 2.6%), a&boa& the 
restenosis group bad a lower rate of i&r&on (1.4% vs. 3.2?b, p = 
0.002). 
tin-. Repeat interveNionat treatment of newly acquired 
steuoses provides a rational approach for the long&m manage- 
ment of cbnmic mrouary artery disease. In addition to yielding a 
favoralde late uutcumq the use uf this strategy can resoit iu 
snstained tima improvement and can heck the progression 
af cRnimuy signi6mnt stenoses. 
(JAm Cdl Gardiol1996:27:1398-405) 
coronary artery surgery. When opting for a surgical approach, 
a significant reduction of symptoms can be anticipated on the 
basis of results of several randomized trials (7,8). However, this 
benefit, appears to be finite in duration. Ten-year follow-up 
data (7-9) reveal an unfortunate trend toward loss of the initial 
angina relief and improved activity tolerance gained through 
the operation. This pattern probably stems from the weil 
recognized tendency of many venous bypass conduits to oc- 
clude within 10 years of implantation (10). The recent prefcr- 
ential use of arterial conduits may improve the long-term 
patency in coronary arteries grafted with these vessels, but 
total arterial revasculatization remains uncommon (11). Re- 
peat operation can be undertaken, but increased mortality and 
reduced success can accompany additional bypass procedures 
(12,13). 
Repeat percutaneous intervention has lcng been consid- 
ered the therapy of choice for appropriate persons experienc- 
ing coronary restenosis within the 1st year after angiopksty 
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(14). However, repeat procedures can also be used to treat new 
coronary stenoses that may arise years after a successful initial 
intervention. Relative to a second or third coronary operation, 
repeat percutaneous intervention provides a potentially more 
attractive approach for several reasons. 1) Medical expenses 
and patient recovery time are generally lower (U-17), reduc- 
ing the financial and social burden of multiple additional 
procedures. 2) Repeat intervention can be attempted with 
anticipated success and complication rates compiirable to 
those of patients undergoing a fhst intervention. 3) Repeat 
!,ercutaneous procedures can probably be continued in the 
future even as a pa:ient ages or acquires comorbidities, factors 
that could preclude candidacy for repeat bypass operation 
(18-20). 
Despite its inherent appeal, the utility of repeat percutane- 
ous coronary intervention as a long-term management strategy 
for new lesions has not previously been subjected to detailed 
formal investigation. This issue is examined in the present 
sludy derived from the 13-year experience of a high volume 
center. 
Methods 
Study patients. Participants in thii investigation were de- 
rived from the 4,357 consecutive interventional cardiac proce- 
dures performed at the Thoraxcenter between September 1980 
and April 1991. This latter date provided a minimum of 2.5 
years of follow-up for every patient in the study. Additional 
criteria for entrance into the current study consisted of 1) two 
or more interventional procedures performed at this or an- 
other facility; 2) a minimum of 7 days separating each proce- 
dure to help eliminate planned staged procedures or un- 
planned repeat intervention due to complications arising from 
the initial procedure; and, 3) lirst interventional procedure 
performed for either stable or unstable aogina but not for 
evolving myocardial infarction. Potential candidates werz iden- 
tilied using the Thoraxcenter interventional data &se, with 
6naI acceptance contingent on verification and thorough re- 
view of all clinicai and procedural records. The 544 patients 
who satisfied all these criteria form the basis of this report. 
Patient cIaasl&atlnn. Each enrolled patient was assigned 
to one of three mutually exclwive groups based on location of 
the target lesion or lesions. The restenosis grcmp had repeat 
interventions limited to the same target segments treated 
during the initial procedure for each and every subsequent 
intervention. In the new stenosis group, all subsequent inter- 
ventions occurred in coronary segments not treated at any time 
previously. The boph group included all remaining patients and 
consisted of those undergoing repeat interventions diiected 
both to the same and to different target segments; these 
interventions may or may not have be-en performed during the 
same repeat procedure. Target coronary segments treated >12 
months after the last intervention in that same segment were 
considered new stenoses and not restenosis (21). Conwary 
segmentaticm was based on the &&cation scheme of the 
American Heart Association (22), with stem >50% con- 
sidered clinically significant. All patients with one or more 
repeat procedures performed in a contiguous coronary artery 
segment (such as the proximal kft anterior descending artery 
in the first procedure and the mid left anterior descending 
artery in the se&d) were analyzed for possible target segment 
misclassification. Those found by careful ana!ysis of records 
and tine films to be categorized incorrectly were reassigned to 
the appropriate group. 
Lang-term follow-up. Follow-up data were obtained by 
using two complementary strategies. First, written inquiries on 
patient whereabouts and vital status were sent to the local Civil 
Registration Service for each of the 544 participants using their 
last known address. In The Netherlands, municipal records 
such as these are gene&y quite accurate and complete. For 
patients who bad moved to new areas, additional inquiries 
were undertaken until the location of their current residence 
was linnly established. Questionnaires were then mailed to all 
living participants. Patients were queried as to current angina 
status with the use of a series of questions designed to reliably 
replicate the New York Heart Association classitkation 
scheme. Information on the occurrence, location and timing of 
cardiac admissions, myocardial infarctions, repeat revascular- 
ization procedures and medication use was also requested. 
Nonresponders were contacted by repeated mailings and ulti- 
mately by telephone. Ambiguous responses were also clarified 
by phone. Overall, 92.7% of personal patient responses were 
obtained. 
Second, additional follow-up data were obtained by record 
review. This source was used to verify positive patient re- 
sponses to queti~~ns on interval myocardial infarctions and 
revascularizati~~n procedures. Outside records were also 
sought and obtained for infarctions and procedures occur&g 
atothermedicalcenters.Becauseoftheinhe.rentinaccuracyof 
theremo~erecaUofsymptorm,themedicalwkordwasusedas 
the sole source of data regarding the presence and severity of 
angina pectoris preceding each interventional procedure. The 
follow-up rate by rexord review was 97.2%. 
DataanaIy& ThedatauweadyzedbyusingtheCLINT 
data base system (23) in conjunction with Bi Data 
Processor version 7.0. Categoric data were compared by using 
the d&square statistic. GMinuous variabk were analyzed by 
using one-way analysis of variance, with the Tnkey muIt@ 
rangetestemployedforposthocintergrcupcompatkns.Life 
tables were calculated according to the Kaplan-Meier method, 
and the general&i Wilcoxon test was selected to deted 
potential differences between groups. Plus over minus values 
represent mean value t SD. Mean diEerences &ted with 
a p value SO.05 were deemed statiskdly sign&ant. 
- @&!at OftheW-pa- 
tients uho un,*rwent repeat procedures 261(48%) had aU 
&sequent interventions limited to retreatment of their initial 
target stenoss or stenoses (restenosis gmup), 155 (28%) 
Mderwelt regeat inte- limited to .stenomthathad 
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Table 1. Patient Characteristics at Initial Procedure 
GIOUF 
Restenosis New Stenosis Both 
(n = 261) (n = 1.55) (II = 12n) 
Age (yr) fmeawwe) s8;30-83 S&33-&1 50;31-79 
Mea 207 (79) 117(75) 103 (no) 
Previous MI 93 w 65 (42) 52 (41) 
Pwioas CABG’ 23 (9) Ifi 22 (17) 
Angina severity (NYHA class) 
I l(O) 2(l) 0 fQ 
II 57 (24) 43 (29) 22(18) 
III 79 (33) Sl(34) 45 (37) 
N 105 (43) 54 (36) 56 (45) 
Iadiitioa for procedure 
Utwable angina :20 (46) 56 (36) 4Y (38) 
Stable angina 141(54) 99 w 79 (62) 
Coronary disease severityt 
Single vessel 172 (66) s (56) 68 (53) 
Double vessel 62 (24) 55 (35) 37 (29) 
Triple vessel 27 (10) 14 (9) 23(18) 
Fxtent of pmcedure’ 
Single lesion/single vessel 175 (67) 124 (80) 84 (65) 
Multilesioa/single vessel ~(181 16 (10) 2.5 (20) 
Maltilesionimultivesl 38(E) 15 (10) 19(15) 
Aagiographic procedural 
SBOXS 
Yes 256 (98! 146 (94) 119 (93) 
partial* 5 (2; 2(l) 2 (4 
NO -- 7 (5) 7 (5) 
Major mmplicatirx~ 
Ui&mt o;sration 0 (0) 2 (1) 3~2) 
Acute MI 2 (1) 3 (2) 4 (3) 
*p c 0.05. tp c 0.01. $Swcessful treatment Lame bn: not all altempted 
target stenmes. Values represent means of continuous rdnableb and cwnts of 
categoric variables, with percentages indicated by parentheses. CABG = cow 
aaly artery bypass surgery; MI = myccardial infarction; NYHA class = New 
York Heart Association faactioaal cl=. 
not been treated previously (new stenosis group) and 128 
(24%) had subsequent procedures directed both to prior target 
stenoses and to new target stenoses (“both” group). As 
detai!ed & Table 1, the three groups were similar with respect 
ta mean age (57 years), gender (78% men) and the presence of 
previous myoc@ial infarction (39%). Prior coronary artery 
surgery was slightly more common (p < 0.05) in patients in the 
“both” group. Most patients had severe angina pectoris before 
intervention (72% in New York Heart Association class III or 
IV), but the pain pattern was deemed stable in the majority 
(59%). No statistically significant differences in angina severity 
or stability were found between groups. 
At the time of the initial procedure (Table l), single-vessel 
disease was more prevaIent in the restenosis group than in 
either the new stenosis or the “both” group (66% vs. 56% and 
53%, respectively, p < 0.01). This observation might be 
explained in part by a greater propensity of patients with 
initiaIIy more severe disease to develop new lesions requiring 
intervention in the future. Despite more single-vessel disease, 
patients in the restenosis group initially received more muiti- 
lesion angioplasty (33% vs. 20% for the new stenosis group, 
p < 0.05). 
Complete angiographic success rates for the initial proce- 
dures were high overall (98% vs. 94rc vs. 93%, p = NS). The 
complete failure rate of 0 for the restenosis group reflects the 
study’s requirement of angiographic success in at least one 
target stenosis in all patients experiencing restenosis in the 
future. Major complications consisted of urgent coronary 
bypass surgery in five patients and acute myocardial infarction 
in nine, with differences bcween groups statistically nonsignif- 
icant. 
Repeat procedures. On average, each patient underwent 
2.36 intcrventional procedures: 13 patients underwent the 
maximal number of 5 interventions. In addition to t5c per 
patient analyses described. the data on all 740 repeat p .‘;ce- 
dures were analyzed on a per procedure basis (Table 2). A 
total of 946 target stenoses were treated during these proce- 
dures; the mean uumber of target stenoses per procedure 
ranged from 1.08 for the restenosis group to 1.52 for the 
.‘both” group. 
Single-vessel disease at the time of the repeat procedures 
was substantially more common in the restenosis group (73% 
vs. 56% for the new stenosis and 51% for the “both” group, 
p < 0.0001) as were single-lesion interventional procedures 
(93% vs. 76% and 56%, respectively, p < 0.0001). The left 
anterior descending artery was a more typical target in the 
restenosis group (54% vs. 31% and 38%, p < 0.0001). Balloon 
angioplasty was the sole device used in 86% of repeat inter- 
ventions, a finding consistent with the era selected for patient 
enrollment. The use of other devices was equally distributed 
among groups (p = NS). 
Complete angiographic success was significantly less fre- 
quent (p < 0.0001) in the new stenosis group (79%) than in the 
restenosis (91%) or the “both” (89%) group. However, major 
complications were rare in all three groups (p = NS). 
The mean time interval separating each interventional 
procedure differed considerably among groups (p < 0.0001) 
(Fig. I j. Whereas patients with resteaesis had an interproce- 
dural interval averaging 4.2 + 2.3 months, patients with new 
stenosis underwent intervention after a much longer interval of 
24.2 t 23.5 months. Patients in the “both” group had an 
intermediate interprocedural interval (11.4 -C 11.0 months). 
Long-term effect on symptoms and disease severity. 
OveraU, the strategy of repeat interventions appears to have 
had a favorable impact on angina status (Fig. 2). For thii 
analysis, we censored patients who had incomplete data on 
initial or fisal angina status; however, the results were virtually 
identical when the analysis was repeated without censoring. At 
the end of 6.2 ? 2.3 years of follow:up, 211 patients (57%j 
were in functional class I. This group includes 61% of the 
patients who were in class III or IV before their ini:iai 
procedure. The mean initial functional c!ass of 3.2 ? 0.8 
decreased to 1.6 f 0.9 at the end of follow-up (p <c 0.0001). 
This analysis can be further expanded by considering symp 
tom status segregated by groups and stratified by time. Figure 
3 reveals that mean functional class was visually and statisti- 
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Table 2. Characteris!ics of Repeat Procedures 
-- --___-.. 
Reitenosis 
-- 
Procedures (no.) 
Target stenw\ (no.) 
Mean target ~.tenowprocedure 
Coronary disease severity’ 
Single wszel 
Douhlc vcsel 
Triple vewl 
Indication for proccduret 
Acute Ml 
Unsrablc angina 
Stahlr angina 
Exlenr of prwcdurc’ 
Single Icsion:single veal 
Multilesionisingle vcswl 
Mulrilesion’multive*wl 
Type of procedure 
Balloon angioplasty 
Coronary b*elt‘nt 
Directional atherectomy 
other 
Angiographic procedural succesf 
Yes 
Partial 
NO 
Major complications 
Death 
Urgev operation 
MI 
Target vtsel (94h Itncns)’ 
RCA 
LAD 
LCX 
Graft 
Prior proazdures (no.)* 
one 
T-0 
Three 
Four 
Time interval between proadores (mob’ 
Pru-dure 1 a. 2 
Procedure 2 vs. 3 
Procedure 3 vs. 4 
Procedure 4 vs. 5 
31 b 
W! 
l.ilx 
177 
2.X) 
l..xl 
247 
375 
I .S? 
230(731 
.(3(1?) 
33 (RI) 
111) 
73 (23) 
239 , 7h) 
293 (93) 
IlV) 
Y (3! 
1lY) (56) l?h(51) 
s3 (34) 73 (al 
24(M) 481191 
10 (6) 7(3) 
il(23j 76 (II) 
i:r,(:l) IM IM! 
265 (84) !5Y (‘10) ?I’(871 
XI (9) lll6J I9 (kl 
19 (6) J (2) ‘(31 
211) 3 (3 6 t3) 
?R7 (91) Hlll?Y) 2lllhYj 
l(O) h (3) I4 IL) 
2x (9) ?I (1X) Illi) 
3(l) 
h(2) 
y (3) 
0 w 
5 (3) 
1-I (8) 
83 (14) 
IW 154) 
E!l5) 
C(h) 
111(33) 
I41 138) 
W(X) 
?I (8) 
I28 (52) 
79 (32) 
29 (12) 
11(J) 
1.2 z 2.3 
1.1 t 1.0 
h.8 f 53 
4.3 + 1.5 
3.5 f 23.8 
32.0 2 3.2 
- 
- 
11.5 -c_ 17.: 
155 f 20.7 
lh.6 1 19.5 
19.3 = 15.5 
New St-mnic Both 
‘p < U.WN. tp < 0.05. $Succesful treatment of some bul not all anempled target stenoss Values represent meam 
of continuous variables and coonfs ofcategoric variables. with percentags iodiated b parentheses. LAD = left anterior 
descending coronary arkry: LCx = left circumflex coronary arten: MI = mjwardial inlarc+ioa. RCA = ngbc awoxq 
artery. 
tally similar just before each procedure (3.2,2.9 and 3.2 hefore ent points in tune (before and immediately after the tint, 
the first, second and third procedures, respectively, p = NS). second and third procedures). As shown, each procedure is 
More important, no significant differences in angina severity accompanied hy a statisticalfy similar improvement in disease 
were observed at any time among the three groups., severity. Moreover. the severity at the start of each procedure 
We sought to assess whether thii substantial functional does not increase with time hut remains relatively antstrmt 
improvement in coronaty disease severity was mirrored try a (1.5 t- 0.7forthehrst, 1.5 f 0.7 forthesecondand 1.6 +,0.7 
corresponding anatomic improvement. Figure 4 dtsplays over- for the third procedure, p = NS). 
all coronary disease severity (quantified hy using the mean I%upusisddiead~ats. Ilteoccurrenceofma- 
number of vessels containing significant stenoses) at six d&r- jar clinicaJ events (death, coronary artery surgery and nonfatal 
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Figure 1. Tlnzedimemional bar graph depicting lbe mean time 
interval separating the current percutaneous coronary interventional 
procedure from its most immediate pr&cessor. The procedure 
number is displayed on the x axis, patients segregated into poups on 
the y axis, and the number of months since the last procedure on the 
a anis. The diEerence between groups was highly signitkant for each 
procedure number (p < O.tMOl), whereas the apparent trend toward 
greater mean time intervals with later procedures was statistically 
rto&&kat. There were no fourth or Mh procedures in the new 
stenosis group. 
myocardial infarction) experienced at any time during the 
study period was determined for 97.2% cf pakipants. Figure 
5 provides lo-par survival curves for each group based on 
Kaplan-Meier estimates. Althortgh the new stenoses group 
show a nonsignkmt trend toward improved survival during 
the 1st 4 years, the overall annual mortality rates were similar 
(l.%, 1.8% and 2% per year. rewctively, for the restenosis, 
Figure 2. New York Heart Association class&a&m of angina severity 
in 368 patients amesed immediately before the initial procedure and 
at iittal follow-up. Patients with incomplete data on angina statas for 
kiherperiodwereexciuded.Thec&mnaa#Ramannemamlsrepre- 
sent angina dasses 1 through Iv; thC v&sea in the squares represent 
patients in that spa& angina ctass at.each time period; 
rconnecting the boxes 1s directll pmpor- 
tional to the nun+ of patients involva them cir&a present 
~valuesof~~forthetwoperiods.Theoverallchanges 
obsemd wete highly signiticant (p C O.ooOl). 
eurrenl 
stahla 
I 
8 
II 
i l l 
IV 
Figure 3. Angina severity represented by mean New York Heart 
Association (NYHA) class, grouped by patients in the restenosis, new 
stenosis or “both” groups. Data are presented for before the first 
procedure (one), before the second procedure (two), before the third 
procedure (three) and for final follow-up (follow-up). The small 
number of patients undergoing more than three procedures preduded 
inclusion of additional data points. The groups did not differ sign& 
car@ from one another at any time point, nor dii the overall data 
differ signiticantly among the first, seczmd and third procedures. 
However, the differences between angina status before each procedure 
and angina status at final follow-up were all highly sign&ant (p < 
0.ooo1). 
new stenosis and “both” groups, p = NS). Figure 6 presents 
analogous curves based on the performance of coronary bypass 
surgery during follow-up. For these analyses, the 61 patients 
(11%) who had undergone coronary surgery before their first 
percutaneous intervention were excluded, because this pre- 
enrollment event could have easily in&need the decision for 
or against surgery during follow-up. Again, the restenosis and 
new stenosis groups demortstrated siiilar event rates (2.3% vs. 
2.6%). The surgery rate for the “both” group was slightly but 
nonsignificantly higher (4.5%, p = NS). Figure 7 provides data 
on the rates of nonfatal myocardial infarction. Unlike previous 
analyses, a signifkaot diierenee was observed between groups, 
with a lower annual infarction rate observed for patients in the 
restenosis group (1.4% vs. 3.2% and 1.8%, respectively; p = 
0.002). 
Discussion 
tLlwa&iisties of repeat pmeedures. The cIhicaI decision 
to attempt repeat intervention obviously depends on many 
factors. including the likelihood of smxess, the,anticipated 
frequency of compkations and the viability of alternative 
modes of treatment. Nevertheless, in the current study the 
threshold for percutaneous intervention, as gauged by prep* 
cedtd angina severity, proved to be similar between the iniial 
pmedtm and all subsequent repeat procedures Tbi pattern 
wasfoundwithbothresknosiaandnewstenc&.fnoontrest, 
the timing of the repeat procedures was quite different. 
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ItPnberotpmcadum 
Fislge 4. Overall coronary disease severity, represented by the mean 
nttmber of major mroaary arteries (or their branches) pcssessing 
stenoses with >50% diameter reduction Vatues for each group are 
presented at six time points-immediately before and after the tIrst, 
ssumd and third interventional procedures. l%e small number of 
patients undergoing more than three procedures preduded ioch@m 
ofthesadditimtlaldatapointsTigroupadidnntdil3ex~ 
fromoneanotberatanypointintime,nordidtbeoveralfdaradi%er 
sigaiticantly when aqariogpreprrzedumlreprocehrralwithooeaaotheror 
whea comparing postpmdural values with one another. However, all 
reductions in severity of aagiogmphic@ asseged d&ease observed at 
each procedure were highly sigoiticmt (p < O.OOOi,. 
Additional procedures for restenosis occurred on average 4 
months after the previous procedure, a time course ma&tent 
with the process of late lumen narrowing (21). However, 
repeat procedures directed to new stenoses were perfxoted on 
average 2 years after the previous intervention. ffiowiedge of 
this time frame might prove useM when assess@ the practi- 
cality of repeat interventions as a long-term strategy. 
Figaro 5. Survival curves for all three groops depicting freedom frwr 
death from any cause for the 1st 10 years of follow-up, based on 
Kaplan-Meier estimates. The numbers of patients at risk at each year 
are shown immediately below the graph. Nwe of the curwzs differ 
signilicantly (p = NS by generalized Wilmxon test) 
p*r* 
- 138 al 206 18(1 ‘?B 9-2s CB e’: ., 23 I‘ 
“~lrlrr ----- 136 ,*3 ‘20 176 701 91 ml 59 37 2’ 18 
109 17 82 LIP 15 %2 50 311 26 ,a 09 
Fv A Curves for ail three groug representing freedom from 
cownary artery bypass surgery (CAEG) for the 1st 10 !ears of 
follo+up. based on KaplaoMeier estimates. Patients a+o hbd under- 
gone coronary surgery before their first percutaneous interventional 
proczdurc were es&led. n; numbers of patients at risk sl each bear 
are presented ittmehtely b&w tbe graph. NOW of the am3 
diiereai sigaiticantiy (p = NS b generalized Wilaxon test). 
The 3ngiogmphk sucas.5 rate for repeat intervention !B this 
study was rot as higtt (p < 0.0001) for new as for xtenotic 
target lesions. ‘Ibis finding mold be anticipated. as it is kamn 
(14) that procedures d&ted to restenotic iesiins ha\r higher 
initial success rates. A more useful mmparison to assess the 
merit of this approach may be with the initial intervention of 
new lesions treated over the same period as the current mhort. 
‘l&NationalHeart,i.uug,andBhxxlInstituteregiuryof 
coronary angioplaq reported complete angiographi sucmss 
rates of 65% and $296, respectively. during the eariy (1977 to 
1981) and late (1985) phase of the study. These rates compare 
with the 79% complete 5ucoesc rateseenforoewsteocaesia 
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*he cmnt study, and suggest that the rticipated success rates 
for repeat interventions of new stenoses . ..dy be comparable to 
that of initial interventions of new lesions. 
Impact on syloptom~ rind adverse events. The strategy of 
repeat percutaneous interventions proved to be quite capable 
of lessening wptoms of angina peooris over the long term, 
with treatment of new stenosis as successful in this regard as 
treatment of restenosis. During a follow-up interval extending 
to I3 years, 58% of patients with angina class III or IV initially 
changed to clslss I. Each repeat procedure on average was able 
to reestablish the magnitude of angina relief experienced with 
the initial intervention. 
Outcomes analysis also establishtd d relatively low rate of 
adverse events for all groups in the study. The Ill-year survival 
rate for our restenosis (81%) and new stenosis (82%) groups 
was similar to the survival figures observed in the Coronary 
Artery Surgery Study (24) for both the medical (79%) and the 
surgical (82%) cohort, although disease severity was probably 
Merent in these two studies. The rate of bypass surgery was 
also statistically similar among three patient groups. Overall, 
despite a higher prevalence of multivessel disease at baseline, 
the patients undergoing repeat procedures for new stenoses 
did as well in three outcome domains (death, bypass surgery 
and symptomatic relief) as did those who underwent repeat 
procedures for restenosis, the latter representing a UCY e-lab- 
lished and widely accepted treatment strategy. 
The observation of a somewhat higher rate of mfarction in 
the new stenosis group tha:r in the restenosis group remains 
both intriguing and unexplained. It is due in part to the higher 
rate of periprocedural myocardial infarction observed in the 
former group during repeat procedures and to the more 
frequent use of interventional procedures for the treatment of 
acute infarction in previously untreated stenoses. However, 
these two factors combined account for only a 10% difference 
in the observed IO-year infarction rates. Other contributory 
factors may include a higher prevalence of multivessel disease 
at baseline and tke possibility of “more aggressive” disease 
associated with the rapid development of new lesions. 
hpact on ~oromuy anatomy. Ideally, repeat interven- 
tionaI procedures performed solely for restenosis might be 
expected b maintain the overall extent of coronary disease at 
or near a constant level over a prolonged period. In the current 
study thii theory was borne out by the patients in whom this 
approach was used. In addition, interventions directed exclu- 
sively to newly developed stenoses accomplished this same 
go& Patients in the new stenosis group had an average of 1.54 
vessels with significant disease before the initial intervention, 
but this number was statistically similar before the second 
(1.55) and third (1.73) procedures despite a time span of 
several years. Similarly, the mean number of diseased vessela 
was O.SS,O.72 and 0.82, respectively, immediately after the first, 
second and third interventional procedures. The treatment 
strategy of multiple repeat percutaneous intervention may 
therefore he able to check the progression of coronary disease 
in selected patients over the lifetime of tke patient. 
poteatial timitations of the study. Among possible limita- 
tions of the present study is the fact that precise categorization 
of a neu,j visualized lesion as either restenotic or new can be 
d&ult or impossible if the stenosis develops near the site of 
an earlier interventional procedure. Although a prospective 
investigation of this issue would have enhanced the reliability 
of our findings, it would probably have proved IogisGcally 
difficult. Second, our conclusions are directly applicable only to 
the subset of patients whose coronary anatomy and clinical 
status permit serial interventions. Third, the outcomes ob- 
served are derived from procedures performed up to a decade 
or more in the past. Because interventional cardiology is such 
a rapidly evolving field, conclusions derived from work done in 
the 19805 may not be directly applicable to the 1990s. Never- 
theless. Jative IO the current study, the superior safety and 
efficacy sf modem percutaneous interventions may predict an 
even more favorable outcome for repeat inrerven!ional proce- 
dures in the future. 
CIinicaI implications. The acute manifestations of coro- 
nary artery disease, suck as unstable angina pectoris or myo- 
cardial infarction, rightly command the greatest attention of 
cardiologists and cardiac interventionalists. However, this fo- 
cus often overshadows the inherently chronic nature of tke 
underlying atherosc!erotic process. When comnary atkeroscle- 
rosis is viewed as a liic!ong disease, it becomes obvious that 
procedures performed during a period of heightened symp- 
toms should be considered 1,7t in isolation but rather as a 
single step in a long-term management strategy that may span 
several decades. 
‘Fhis study kelps validate the use cf repeat interventional 
procedures in the management of progressive coronary artery 
disease. This approach resulted in a clear decrease in symp 
tams during follow-up of up to 13 years, a period during which 
coronary bypass surgery used as a single procedure tends to 
lose its effectiveness (4). Adverse events were relatively infre- 
quent, with a good U&year survival rate observed. perhaps 
most remarkable was the abilily of this strategy of raultiple 
repeat procedures to maintam the severity of angiographic 
disease below its level at initial presentation, even though riew 
stenoses developed during follow-up with regular frequency 
These data suggest that the use of repeat coronary interventions 
should be considered a rational long-term treatment strategy for 
appropriate patients with atkeroscleratic heart disease. 
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